Home » Topics » Regulatory

Regulatory
RSS

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

FDA advisory panel will review MS indication for Novantrone in early 2000

Dec. 8, 1999

Nasonex Nasal Spray approved for new pediatric indication in U.S.

Dec. 3, 1999

FDA approves new epilepsy treatment

Dec. 2, 1999

V1A/AT1 receptor antagonist combinations for cardiovascular disorders

Dec. 2, 1999

Combinations of imidazoles for female genital infections

Dec. 1, 1999

NMDA antagonists reported to be useful for IBS

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

New Zomig formulation receives European regulatory approval

Nov. 25, 1999

U.S. academic team takes a novel approach to treating prostate cancer

Nov. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...